{
  "timestamp": "20250104_032057",
  "model": "gpt-4-turbo",
  "interaction_type": "enhancement_with_chain_kg_only",
  "question_id": "602a9994",
  "question_text": "Propronolol is useful in all except -",
  "messages": [
    {
      "role": "system",
      "content": "You are a medical expert making decisions based on enhanced information and careful verification."
    },
    {
      "role": "user",
      "content": "You are a medical expert specializing in Pharmacology.\n        Your task:\n        - You have per-option reasoning chains (from previous step).\n        - You have retrieved evidence paths (enhanced graph info) that are correct but may be broad and not directly addressing the key point.\n        - Use standard medical/biochemical consensus to evaluate each chain.\n        - If a chain step contradicts consensus, correct or remove it.\n        - Check evidence paths: if they provide relevant support or clarify consensus, incorporate them.\n        - If paths are too broad or not relevant, do not let them mislead you.\n        - Aim to produce a final \"enhanced_information\" that:\n          1. Reflects corrected, consensus-aligned reasoning for each option,\n          2. Integrates helpful evidence from paths,\n          3. Excludes misleading or irrelevant info,\n          4. Focuses on what best helps answer the question correctly.\n\n        ### Question\n        Propronolol is useful in all except -\n\n        ### Options\n        opa. Atrial flutter\nopb. Parkinsonian tremor\nopc. Thyrotoxicosis\nopd. HOCM\n\n### Reasoning Chains per Option:\nCHAIN: \"Propranolol\" -> \"non-selective beta-blocker\" -> \"reduces sympathetic nervous system activity\" -> \"decreases heart rate and contractility\" -> \"useful in atrial flutter\" -> 95%\nCHAIN: \"Propranolol\" -> \"non-selective beta-blocker\" -> \"reduces sympathetic nervous system activity\" -> \"decreases tremors\" -> \"useful in Parkinsonian tremor\" -> 80%\nCHAIN: \"Propranolol\" -> \"non-selective beta-blocker\" -> \"blocks beta receptors\" -> \"reduces symptoms of thyrotoxicosis\" -> \"useful in thyrotoxicosis\" -> 90%\nCHAIN: \"Propranolol\" -> \"non-selective beta-blocker\" -> \"decreases heart rate and contractility\" -> \"may worsen outflow obstruction\" -> \"not useful in HOCM\" -> 85%\n\n### Retrieved Evidence Paths (broad but correct):\n(Tremor)-CAUSES->(Parkinsonian tremor)\n\n        ### Instructions:\n        1. Recall standard consensus facts relevant to the question.\n        2. For each option's chain, compare steps to consensus and paths:\n           - Remove/adjust steps contradicting known facts.\n           - If paths confirm or clarify a point aligned with consensus, use them.\n           - Ignore irrelevant or overly broad paths that don't help.\n        3. If uncertain, note uncertainty but choose the best consensus-supported interpretation.\n        4. Output a short \"enhanced_information\" summarizing the corrected reasoning and relevant evidence that truly aids in final answer determination.\n\n        ### Output Format:\n        {\n          \"enhanced_information\": \"A concise, consensus-aligned summary integrating corrected reasoning and relevant evidence.\"\n        }\n        "
    }
  ],
  "response": "### Enhanced Information Summary\n\nPropranolol, a non-selective beta-blocker, is known to reduce sympathetic nervous system activity, which affects heart rate and contractility. This makes it useful in conditions where a reduction in heart rate and contractility is beneficial.\n\n1. **Atrial Flutter**: Propranolol's ability to decrease heart rate makes it beneficial in managing atrial flutter, as slowing the heart rate can help control the rhythm disturbance characteristic of this condition.\n\n2. **Parkinsonian Tremor**: Although propranolol is effective in reducing some types of tremors due to its beta-blocking effects, its use in Parkinsonian tremor is not typically recommended as a primary treatment. Parkinsonian tremor primarily arises from dopamine deficiency and other central nervous system alterations, which are not directly influenced by beta-blockers. The retrieved evidence path linking tremor broadly to Parkinsonian tremor does not specifically support the use of propranolol in this condition, as it does not address the unique pathophysiology of Parkinson's disease.\n\n3. **Thyrotoxicosis**: Propranolol is effective in managing symptoms of thyrotoxicosis, such as tachycardia and anxiety, by blocking beta receptors. This helps mitigate the excessive thyroid hormone effects on the cardiovascular system.\n\n4. **Hypertrophic Obstructive Cardiomyopathy (HOCM)**: In HOCM, the primary issue is the obstruction of blood flow due to thickened heart muscle. While propranolol reduces heart rate and contractility, in HOCM, this can paradoxically worsen the obstruction by increasing the duration of ventricular contraction and potentially exacerbating the obstruction. Therefore, propranolol is generally not recommended in HOCM.\n\n**Conclusion**: Based on the medical consensus and the specific actions of propranolol, it is useful in atrial flutter and thyrotoxicosis but not recommended as a primary treatment for Parkinsonian tremor and is contraindicated in HOCM due to the potential for worsening the condition.\n\n```json\n{\n  \"enhanced_information\": \"Propranolol is beneficial in atrial flutter and thyrotoxicosis due to its beta-blocking effects on heart rate and symptoms. However, it is not the primary treatment for Parkinsonian tremor, where central nervous system changes are predominant, and is contraindicated in HOCM, where it may worsen blood flow obstruction.\"\n}\n```",
  "metadata": {
    "topic": "Pharmacology",
    "is_multi_choice": true,
    "has_reasoning_chain": true,
    "has_enhanced_info": true,
    "model_config": "gpt-4-turbo",
    "temperature": 0.0
  }
}